O

OptimizeRx Corp
D

OPRX

5.40000
USD
-0.04
(-0.74%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-4
Market Cap
99,472,892
Related Instruments
    ALL
    ALL
    -0.480
    (-0.26%)
    184.560 USD
    CNC
    CNC
    1.560
    (2.46%)
    65.100 USD
    HCA
    HCA
    5.71
    (1.79%)
    325.29 USD
    H
    HSTM
    0.080
    (0.25%)
    32.150 USD
    UNH
    UNH
    10.46
    (2.01%)
    529.65 USD
    More
News

Title: OptimizeRx Corp

Sector: Healthcare
Industry: Health Information Services
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging,Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.